G. Helbig, “OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE”, Mediterr J Hematol Infect Dis, vol. 7, no. 1, p. e2015003, Jan. 2015.